http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GT-201400031-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355
filingDate 2014-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0afb19033d017a501e5370f2a5d049e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91d7b1bfc855cdd61c0a6e49f9608668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b625bd4eee9d3f813cd942754390fac5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e8811aa3ca033ff1dbf9002fb8d4df5
publicationDate 2015-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GT-201400031-A
titleOfInvention DERIVATIVES OF 2-AMINO-4- (PIRIDIN-2-IL) -5,6-DIHIDRO-4H-1,3-OXAZINE AND ITS USE AS BACE-1 AND / OR BACE-2 INHIBITORS
abstract THE INVENTION REFERS TO NEW DERIVATIVES OF FORMULA OXAZINE (I), AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, IN WHICH ALL THE VARIABLES ARE AS DEFINED IN THE SPECIFICATION, PHARMACEUTICAL COMPOSITIONS OF THE SAME, THE COMMISSIONS OF THEM, THEIR BOTH USE AS MEDICATIONS, PARTICULARLY FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR DIABETES THROUGH THE INHIBITION OF BACE-1 OR BACE-2.
priorityDate 2011-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12313776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208039

Total number of triples: 28.